Search for a report

EUROPE BIOCHIPS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Downloads
  • EUROPE BIOCHIPS MARKET FORECAST 2019-2028

EUROPE BIOCHIPS MARKET FORECAST 2019-2028

The Europe biochips market is estimated to register a CAGR of 12.98% over the forecast period of 2019-2028. The European biochips market withholds high prospects of growth due to ongoing developments in next-generation sequencing techniques and the presence of renowned players that have adopted significant strategies, such as product launch and acquisition, to increase their market share.

EUROPE BIOCHIPS MARKET FORECAST 2019-2028

Europe Biochips Market By Type (dna Chips, Lab On A Chip, Protein Chips, Other Chips) By Substrate Materials (glass, Polymers, Silicon, Other Substrate Materials) By End-users (biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institute) By Geography.

Request free sample

The Europe biochips market is estimated to register a CAGR of 12.98% over the forecast period of 2019-2028. The European biochips market withholds high prospects of growth due to ongoing developments in next-generation sequencing techniques and the presence of renowned players that have adopted significant strategies, such as product launch and acquisition, to increase their market share.
Europe Biochips Market

To know more about this report, request a free sample copy.

The Europe biochips market growth is studied by evaluating the markets of Russia, the UK, Germany, Belgium, France, Poland, Italy, and the rest of Europe. In the UK, the healthcare expenditure of 9.8% of the GDP. Lab on a chip is gaining attention, as microfluidics witnessed an increased use in POC diagnostics. With the increasing burden of chronic diseases, POC tests are in demand in the UK. The UK government has spent a considerable amount to develop and make the country a global hub for biochip technologies. Germany is one of the preferred locations by biotech companies for R&D facilities. The proteomics and genomics industry in the country is growing. Germany spends about 11% of the GDP on healthcare per capita, as the healthcare industry is prioritized in the country. The increasing R&D of microfluidics has led to its development.

France spends a significant amount of its GDP on the healthcare sector. Microfluidics is expanding rapidly, stimulated by an impressive number of applications in chemistry and biology. The French national cancer institute aims at supporting cancer biomarkers, biochip technologies, and genomic studies, which helps to develop biochip technology and drive the market. In Italy, the rise in demand for POCT and increasing drug discovery are augmenting the market growth. Various academic institutions are researching on microfluidic devices.

Randox Laboratories Ltd, headquartered in Antrim, Northern Ireland, the UK, is a clinical diagnostic company that manufactures and provides diagnostic solutions to laboratories. In March 2020, the company, along with Bosch Healthcare Solutions, developed one of the world’s first, fully-automated molecular diagnostic tests.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
      • DEVELOPMENT OF BIOCHIPS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • RISING INCIDENCES OF CHRONIC DISEASES
        • GROWING INTEREST IN PERSONALIZED MEDICINES
        • APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
        • RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
      •    KEY RESTRAINTS
        • HIGH INSTRUMENTATION COST
        • LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
        • AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
        • COMPLEXITY OF BIOLOGICAL SYSTEMS
        • LACK OF COMMON REGULATORY STANDARDS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON BIOCHIPS
      • KEY INVESTMENT INSIGHTS
      •    PORTER’S FIVE FORCE ANALYSIS
        • BUYER POWER
        • SUPPLIER POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      •    VALUE CHAIN ANALYSIS
        • RESEARCH & DEVELOPMENT
        • RAW MATERIALS
        • MANUFACTURING
        • WHOLESALERS/RETAILERS/DISTRIBUTORS
        • END-USER
      •    KEY BUYING CRITERIA
        • COST
        • APPLICATIONS
        • PRODUCT TYPE
      • REGULATORY FRAMEWORK
    2. MARKET BY TYPE
      •    DNA CHIPS
        • AGRICULTURAL BIOTECHNOLOGY
        • CANCER DIAGNOSIS & TREATMENT
        • DRUG DISCOVERY
        • GENE EXPRESSION
        • GENOMICS
        • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
        • OTHER DNA CHIPS
      •    LAB ON A CHIP
        • CLINICAL DIAGNOSTICS
        • DRUG DISCOVERY
        • GENOMICS
        • POINT OF CARE & IN VITRO DIAGNOSIS
        • PROTEOMICS
        • OTHER LAB ON A CHIP
      •    PROTEIN CHIPS
        • DIAGNOSTICS
        • DRUG DISCOVERY
        • EXPRESSION PROFILING
        • HIGH THROUGHPUT SCREENING
        • PROTEOMICS
        • OTHER PROTEIN CHIPS
      •    OTHER TYPES
        • CELL ARRAYS
        • TISSUE ARRAYS
    1. MARKET BY SUBSTRATE MATERIALS
      • GLASS
      • POLYMERS
      • SILICON
      • OTHER SUBSTRATE MATERIALS
    2. MARKET BY END-USER
      • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
      • HOSPITALS AND DIAGNOSTICS CENTERS
      • ACADEMIC AND RESEARCH INSTITUTES
    3. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    1. COMPANY PROFILES
      • ABBOTT LABORATORIES INC
      • AGILENT TECHNOLOGIES INC
      • BIOCHAIN INSTITUTE INC
      • BIOMÉRIEUX SA
      • BIO-RAD LABORATORIES INC
      • CEPHEID
      • CYBRDI INC
      • F HOFFMANN-LA ROCHE LTD
      • FLUIDIGM CORPORATION
      • GE HEALTHCARE
      • ILLUMINA INC
      • MERCK KGAA
      • PERKINELMER INC
      • RANDOX LABORATORIES LTD
      • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – BIOCHIPS

    TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018

    TABLE 3: REGULATORY FRAMEWORK

    TABLE 4: EUROPE BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: EUROPE BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: EUROPE BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 7: EUROPE BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 8: EUROPE BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 9: EUROPE BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 10: EUROPE BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 11: EUROPE BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 12: EUROPE BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 13: EUROPE BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 14: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS

    TABLE 15: EUROPE BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 16: EUROPE BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 17: EUROPE BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 18: EUROPE BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 19: EUROPE BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 20: EUROPE BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    LIST OF FIGURES

    FIGURE 1: DEVELOPMENT OF BIOCHIPS

    FIGURE 2: KEY INVESTMENT INSIGHTS

    FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: VALUE CHAIN ANALYSIS

    FIGURE 7: KEY BUYING CRITERIA

    FIGURE 8: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019

    FIGURE 9: EUROPE BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 10: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019

    FIGURE 11: EUROPE BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)

    FIGURE 12: EUROPE BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)

    FIGURE 13: EUROPE BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 14: EUROPE BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 15: EUROPE BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 16: EUROPE BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)

    FIGURE 17: EUROPE BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 18: EUROPE BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)

    FIGURE 19: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019

    FIGURE 20: EUROPE BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)

    FIGURE 21: EUROPE BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 22: EUROPE BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 23: EUROPE BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)

    FIGURE 24: EUROPE BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 25: EUROPE BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)

    FIGURE 26: EUROPE BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 27: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019

    FIGURE 28: EUROPE BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)

    FIGURE 29: EUROPE BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)

    FIGURE 30: EUROPE BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)

    FIGURE 31: EUROPE BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)

    FIGURE 32: EUROPE BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)

    FIGURE 33: EUROPE BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)

    FIGURE 34: EUROPE BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)

    FIGURE 35: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019

    FIGURE 36: EUROPE BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)

    FIGURE 37: EUROPE BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)

    FIGURE 38: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019

    FIGURE 39: EUROPE BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)

    FIGURE 40: EUROPE BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)

    FIGURE 41: EUROPE BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)

    FIGURE 42: EUROPE BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)

    FIGURE 43: EUROPE BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019

    FIGURE 44: EUROPE BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)

    FIGURE 45: EUROPE BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)

    FIGURE 46: EUROPE BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)

    FIGURE 47: EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

    FIGURE 48: UNITED KINGDOM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 49: GERMANY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 50: FRANCE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 51: ITALY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 52: RUSSIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 53: BELGIUM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 54: POLAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 55: REST OF EUROPE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    1. MARKET BY TYPE
      •    DNA CHIPS
        • AGRICULTURAL BIOTECHNOLOGY
        • CANCER DIAGNOSIS & TREATMENT
        • DRUG DISCOVERY
        • GENE EXPRESSION
        • GENOMICS
        • SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
        • OTHER DNA CHIPS
      •    LAB ON A CHIP
        • CLINICAL DIAGNOSTICS
        • DRUG DISCOVERY
        • GENOMICS
        • POINT OF CARE & IN VITRO DIAGNOSIS
        • PROTEOMICS
        • OTHER LAB ON A CHIP
      •    PROTEIN CHIPS
        • DIAGNOSTICS
        • DRUG DISCOVERY
        • EXPRESSION PROFILING
        • HIGH THROUGHPUT SCREENING
        • PROTEOMICS
        • OTHER PROTEIN CHIPS
      •    OTHER TYPES
        • CELL ARRAYS
        • TISSUE ARRAYS
    1. MARKET BY SUBSTRATE MATERIALS
      • GLASS
      • POLYMERS
      • SILICON
      • OTHER SUBSTRATE MATERIALS
    2. MARKET BY END-USER
      • BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
      • HOSPITALS AND DIAGNOSTICS CENTERS
      • ACADEMIC AND RESEARCH INSTITUTES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now